Empagliflozin for the preservation of beta‐cell function in women with recent gestational diabetes: A randomized placebo‐controlled trial

Documenti analoghi

• Role of the liver in the sustained normalisation of A1c over 2 years following short‐term insulin therapy in early type 2 diabetes
  di: Andrew Wu, et al.
  Pubblicazione: (2024)
• Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial
  di: Minji Sohn, et al.
  Pubblicazione: (2024)
• SGLT2 inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial
  di: Didde Kidmose Kristensen, et al.
  Pubblicazione: (2024)
• Effect of alirocumab on postprandial hyperlipidaemia in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, cross‐over trial
  di: Bertrand Cariou, et al.
  Pubblicazione: (2025)
• Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
  di: Xianglin Wu, et al.
  Pubblicazione: (2025)